Common Stock, Shares, Outstanding of bluebird bio, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
bluebird bio, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • bluebird bio, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2025 was 9,790,000, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

bluebird bio, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 9,790,000 -183,793,000 -95% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 9,728,000 +89,000 +0.92% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 193,917,000 +86,895,000 +81% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 193,856,000 +87,402,000 +82% 30 Jun 2024 10-Q 27 Sep 2024 2024 Q2
Q1 2024 193,583,000 +87,213,000 +82% 31 Mar 2024 10-Q 13 Sep 2024 2024 Q1
Q4 2023 9,639,000 -73,284,000 -88% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 107,022,000 +24,142,000 +29% 30 Sep 2023 10-K 13 Sep 2024 2023 FY
Q2 2023 106,454,000 +32,903,000 +45% 30 Jun 2023 10-K 13 Sep 2024 2023 FY
Q1 2023 106,370,000 +34,932,000 +49% 31 Mar 2023 10-K 13 Sep 2024 2023 FY
Q4 2022 82,923,000 +11,808,000 +17% 31 Dec 2022 10-K 13 Sep 2024 2023 FY
Q3 2022 82,880,000 +12,783,000 +18% 30 Sep 2022 10-K 13 Sep 2024 2023 FY
Q2 2022 73,551,000 +6,000,000 +8.9% 30 Jun 2022 10-K 13 Sep 2024 2023 FY
Q1 2022 71,438,000 +4,016,000 +6% 31 Mar 2022 10-K 13 Sep 2024 2023 FY
Q4 2021 71,115,000 +4,683,000 +7% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 70,097,000 +3,758,000 +5.7% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 67,551,000 +1,355,000 +2% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 67,422,000 +11,802,000 +21% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 66,432,000 +11,064,000 +20% 31 Dec 2020 10-K 04 Mar 2022 2021 FY
Q3 2020 66,339,000 +11,019,000 +20% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 66,196,000 +10,968,000 +20% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 55,620,000 +551,000 +1% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 55,368,000 +630,000 +1.2% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 55,320,000 +642,000 +1.2% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 55,228,000 +5,003,000 +10% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 55,069,000 +5,002,000 +10% 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 54,738,000 +5,332,000 +11% 31 Dec 2018 10-K 18 Feb 2020 2019 FY
Q3 2018 54,678,000 +8,893,000 +19% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 50,225,000 +4,686,000 +10% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 50,067,000 +9,144,000 +22% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 49,406,000 +8,715,000 +21% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 45,785,000 +8,489,000 +23% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 45,539,000 +8,537,000 +23% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 40,923,000 +3,986,000 +11% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 40,691,000 +3,797,000 +10% 31 Dec 2016 10-K 21 Feb 2018 2017 FY
Q3 2016 37,296,000 +655,000 +1.8% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 37,002,000 +1,044,000 +2.9% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 36,937,000 +4,244,000 +13% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 36,894,000 +4,554,000 +14% 31 Dec 2015 10-K 22 Feb 2017 2016 FY
Q3 2015 36,641,000 +12,701,000 +53% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 35,958,000 +10,881,000 +43% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 32,693,000 +8,414,000 +35% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 32,340,000 +8,400,000 +35% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 23,940,000 +307,000 +1.3% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 25,077,000 +1,474,000 +6.2% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 24,279,000 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 23,940,000 +23,631,000 +7648% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q3 2013 23,633,000 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 23,603,000 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q4 2012 309,000 31 Dec 2012 10-K 05 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.